Celiprolol
As of the edition of 20 October 2026, Celiprolol is a small molecule: marketed, first approved in 1987 (FR); acts on ADRA2A, ADRA2B and ADRA2C and 1 more.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1987
- Kind
- Small molecule
- Brand name
- Celectol
- First approved
- 5 March 1987 (FR)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Registered trials
- 3, 0 stopped early
- Disease areas
- Blood and lymph; Heart and blood vessels; Inherited and neonatal; Skin and connective tissue; Lungs and airways
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 3 | 1 | 0 | 1 | 0 |
| Phase 4 | 2 | 2 | 0 | 0 |
| All trials | 3 |